Oncology News
News travels fast and there are very few places where you can find a concentrated collection of news and insights for the oncology field. As the North Carolina Society of Oncology Practice Managers, we regularly work to publish news and content relevant to managing an oncology practice in North Carolina. The articles published here are pertinent to our industry and the issues currently affecting oncology practices.
- U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib)
- Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
- FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression
- Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
- FDA approves inotuzumab ozogamicin for pediatric patients with acute lymphoblastic leukemia
- PharmaEssentia’s BESREMi (ropeginterferon alfa-2b-njft) Now Recommended as a Preferred First-line Cytoreductive Therapy for Polycythemia Vera in Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
- RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA
- FDA approves bosutinib for pediatric patients with chronic myelogenous leukemia
- Annexus Health Celebrates Milestones, Innovation, and Transformational Growth in 2023
Interested in Joining NCOMS?
Let’s Talk!
Interested in Joining NCOMS?
Let’s Talk!
Fill out the form below to start the conversation.
We look forward to chatting!
Fill out the form below to start the conversation.
We look forward to chatting!